BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19773440)

  • 1. Adipocytes impair leukemia treatment in mice.
    Behan JW; Yun JP; Proektor MP; Ehsanipour EA; Arutyunyan A; Moses AS; Avramis VI; Louie SG; Butturini A; Heisterkamp N; Mittelman SD
    Cancer Res; 2009 Oct; 69(19):7867-74. PubMed ID: 19773440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy.
    Pramanik R; Sheng X; Ichihara B; Heisterkamp N; Mittelman SD
    Leuk Res; 2013 May; 37(5):503-9. PubMed ID: 23332453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine.
    Ehsanipour EA; Sheng X; Behan JW; Wang X; Butturini A; Avramis VI; Mittelman SD
    Cancer Res; 2013 May; 73(10):2998-3006. PubMed ID: 23585457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
    Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
    Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia.
    Parameswaran R; Lim M; Arutyunyan A; Abdel-Azim H; Hurtz C; Lau K; Müschen M; Yu RK; von Itzstein M; Heisterkamp N; Groffen J
    J Exp Med; 2013 Apr; 210(4):805-19. PubMed ID: 23478187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation.
    Siebert A; Goren I; Pfeilschifter J; Frank S
    PLoS One; 2016; 11(12):e0168562. PubMed ID: 27992530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer properties of vincristine is modulated by microRNAs in acute lymphoblastic leukemia Nalm6 cell line.
    Shirazi-Tehrani E; Vafadar A; Keshavarzi M; Firouzabadi N
    Anticancer Drugs; 2022 Jan; 33(1):e680-e685. PubMed ID: 34459460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of De Novo Adipocyte Differentiation Through Cross Talk Between Adipocytes and Preadipocytes.
    Challa TD; Straub LG; Balaz M; Kiehlmann E; Donze O; Rudofsky G; Ukropec J; Ukropcova B; Wolfrum C
    Diabetes; 2015 Dec; 64(12):4075-87. PubMed ID: 26340931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.
    Vilas-Zornoza A; Agirre X; Abizanda G; Moreno C; Segura V; De Martino Rodriguez A; José-Eneriz ES; Miranda E; Martín-Subero JI; Garate L; Blanco-Prieto MJ; García de Jalón JA; Rio P; Rifón J; Cigudosa JC; Martinez-Climent JA; Román-Gómez J; Calasanz MJ; Ribera JM; Prósper F
    Leukemia; 2012 Jul; 26(7):1517-26. PubMed ID: 22307227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines.
    Stanciu-Herrera C; Morgan C; Herrera L
    Leuk Res; 2008 Apr; 32(4):625-32. PubMed ID: 17706771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of MKP-5 in Adipocyte-Macrophage Interactions during Obesity.
    Lu Y; Ma J; Zhao J; Song Z; Zhou C; Liu X; Teng W; Wang W; Zhang Q; Yan W; Jiao P
    Obes Facts; 2020; 13(1):86-101. PubMed ID: 31962332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response.
    Sheng X; Tucci J; Parmentier JH; Ji L; Behan JW; Heisterkamp N; Mittelman SD
    Oncotarget; 2016 Nov; 7(45):73147-73159. PubMed ID: 27705905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal vincristine for the treatment of human acute lymphoblastic leukaemia in severe combined immunodeficient (SCID) mice.
    Millar JL; Millar BC; Powles RL; Steele JP; Clutterbuck RD; Mitchell PL; Cox G; Forssen E; Catovsky D
    Br J Haematol; 1998 Aug; 102(3):718-21. PubMed ID: 9722298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish-oil-derived n-3 polyunsaturated fatty acids reduce NLRP3 inflammasome activity and obesity-related inflammatory cross-talk between adipocytes and CD11b(+) macrophages.
    De Boer AA; Monk JM; Liddle DM; Hutchinson AL; Power KA; Ma DW; Robinson LE
    J Nutr Biochem; 2016 Aug; 34():61-72. PubMed ID: 27208584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha.
    Suganami T; Nishida J; Ogawa Y
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2062-8. PubMed ID: 16123319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Efficacy of
    Heendeniya SN; Keerthirathna LR; Manawadu CK; Dissanayake IH; Ali R; Mashhour A; Alzahrani H; Godakumbura P; Boudjelal M; Peiris DC
    Biomolecules; 2020 Jan; 10(2):. PubMed ID: 31973079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAD001 (everolimus) induces dose-dependent changes to cell cycle regulation and modifies the cell cycle response to vincristine.
    Saunders PO; Weiss J; Welschinger R; Baraz R; Bradstock KF; Bendall LJ
    Oncogene; 2013 Oct; 32(40):4789-97. PubMed ID: 23128395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study.
    Chevallier P; Huguet F; Raffoux E; Etienne A; Leguay T; Isnard F; Robillard N; Guillaume T; Delaunay J; Charbonnier A; Pigneux A; Peterlin P; Bené MC; Wegener WA; Goldenberg DM; Dombret H
    Haematologica; 2015 Apr; 100(4):e128-31. PubMed ID: 25552705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.